Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/103.CBwb5WV5.js ...

Predicting who will transition from acute to chronic pain is the “holy grail” of pain neuroscience. A novel biomarker ...

A novel biomarker signature that assessed cortical activity predicted individual pain sensitivity, the PREDICT validation ...

Motif Neurotech has received a multi-million dollar grant to support the development of a therapeutic brain-computer ...

Motif’s BCI technology is designed to monitor and regulate mental and cognitive states without a need for brain surgery.

The Fastfrate Group, a Canadian leader in transportation and logistics, is proud to announce that, together with their parent ...

Motif Neurotech, a Houston-based neurotechnology company, today announced their selection by UK’s Advanced Research and ...

Yet, while much attention is directed at this move, a far more profound challenge looms. The rise of artificial intelligence (AI) that processes and generates human-like language, as well as ...

at 06:05 Motif Neurotech Wins UK Government Award to Develop Therapeutic Brain-Computer Interface Motif Neurotech, a Houston-based neurotechnology company, today announced their selection by UK's ...

Co-founder and CEO Jacob Robinson explains how Motif designed the neurostimulation system to treat depression like a pacemaker for the brain. Northwestern University researchers said their device ...